Status:
UNKNOWN
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
Lead Sponsor:
Hellenic Cooperative Oncology Group
Collaborating Sponsors:
Stavros Niarchos Foundation
Care Across Ltd
Conditions:
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to provide high quality oncology services to patients with inoperable Non-Small Cell Lung Cancer (NSCLC) in Greece. These services will be based on 3 pillars: 1. Clinical...
Detailed Description
Lung cancer is the primary cause of cancer death worldwide regardless of gender or age group. Based on the most recent statistics for our country, every year about 9000 new cases of lung cancer are di...
Eligibility Criteria
Inclusion
- Patients with non-small cell lung cancer stage IV
- No younger than 18 years old patients
- Performance status: 0-2
- Existence of biological material for the molecular analysis
- Patients who have not been treated with any other treatment than adjuvant
- Ability to use a mobile device or computer for digital communication
Exclusion
- Childbearing women
- Patients with PS \> 3
- Limited ability to use a mobile device for basic digital communication
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05372081
Start Date
March 23 2022
End Date
March 1 2025
Last Update
May 13 2022
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Ygeia Hospital
Psychikó, Attica, Greece, 15123
2
MITERA Hospital
Athens, Marousi, Greece, 15123
3
General University Hospital of Larissa
Larissa, Mezourlo, Greece, 41110
4
3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital
Athens, Nea Kifisia, Greece, 14564